Form 8-K - Current report:
SEC Accession No. 0001104659-18-063797
Filing Date
2018-10-25
Accepted
2018-10-25 06:48:40
Documents
6
Period of Report
2018-10-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-37128_18k.htm 8-K 32110
2 EX-99.1 a18-37128_1ex99d1.htm EX-99.1 813211
3 EX-99.2 a18-37128_1ex99d2.htm EX-99.2 995086
4 EX-99.3 a18-37128_1ex99d3.htm EX-99.3 16230
5 GRAPHIC g371281mmi001.jpg GRAPHIC 3258
6 GRAPHIC g371281mqi001.jpg GRAPHIC 3258
  Complete submission text file 0001104659-18-063797.txt   1867220
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 181137554
SIC: 2834 Pharmaceutical Preparations